agilon health (AGL) 2024 Wells Fargo Healthcare Conference summary

Financial performance and cost trends

• Cost trend expectations for Q1 were reduced from over 10% to 8.2%, with Q2 at 7.3% and Q3 forecasted at 6% due to dynamic utilization and seasonality.

• Inpatient medical costs remain elevated but are trending lower in Q2 versus Q1, with ongoing monitoring of Two-Midnight Rule impacts.

• Retroactive contract termination and new member growth affected PMPM yields, with risk adjustment data leading to guidance at the lower end of the previous range.

• Cash burn for the year is projected at $125–$150 million, with $408 million on the balance sheet and improved cash flow expected next year.

• Enhanced data visibility and a new financial data pipeline will provide more real-time insights and support better reserving and forecasting.

Growth, partnerships, and operational initiatives

• The 2024 cohort is the largest and performing well, with strong partners and early implementation of clinical programs.

• Growth strategy emphasizes prudent expansion, focusing on existing markets for lower risk and leveraging established infrastructure.

• Hospital partnerships are progressing, with three health system partners integrating successfully and contributing to network expansion.

• Same-store growth is targeted at or above local rates, with physician engagement and performance reviews driving improvements.

• Clinical initiatives, such as oncology infusion and MSK programs, are being piloted to address high-cost areas and optimize site-of-service utilization.

Contracting, payer dynamics, and future outlook

• 2025 payer bids are under review, with 50% of membership bids received and detailed analysis ongoing.

• Part D changes under the Inflation Reduction Act are prompting active negotiations to carve out or corridor benefits, aiming to reduce volatility.

• 40% of contracts are up for renewal in 2025, with all contracts to be repriced by 2027, incorporating new terms to mitigate risk.

• Value-based care proposition is increasingly attractive to payers, with demonstrated performance 200–300 basis points above fee-for-service benchmarks.

• ACO REACH membership exceeded expectations, with bipartisan support for future models post-2026 and continued strong performance.